Yes, for sure I do. I think the governing council would actually make decisions about large strategic initiatives. It could, for example, launch an initiative on research into the impact of patented medicines on pharmacare programs, as I mentioned in my presentation. Or it may actually decide that overall there has to be more emphasis on or more support for the drug safety and effectiveness network. If these large strategic decisions are not made at the governing council level, I do not know where they are made.
